Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune response to Clostridium difficile infection

C P Kelly1

  • 1Beth Israel Hospital, Harvard Medical Schoo, Boston, MA, USA.

European Journal of Gastroenterology & Hepatology
|November 1, 1996
PubMed
Summary

Immune responses to Clostridium difficile toxins A and B influence disease severity. Understanding these antitoxin responses is key to developing new treatments for C. difficile infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mid-term results of a stemless ceramic on polyethylene shoulder prosthesis - A prospective multicentre study.

Shoulder & elbow·2021
Same author

Reliability of stemless shoulder arthroplasty in rheumatoid arthritis: observation of early lysis around the humeral component.

Musculoskeletal surgery·2019
Same author

Revision shoulder arthroplasty for failed surface replacement hemiarthroplasty.

Musculoskeletal surgery·2018
Same author

Factors associated with villus atrophy in symptomatic coeliac disease patients on a gluten-free diet.

Alimentary pharmacology & therapeutics·2017
Same author

Lack of adherence to SHEA-IDSA treatment guidelines for Clostridium difficile infection is associated with increased mortality.

The Journal of antimicrobial chemotherapy·2017
Same author

Creation of a model to predict survival in patients with refractory coeliac disease using a multinational registry.

Alimentary pharmacology & therapeutics·2016

Area of Science:

  • Microbiology
  • Immunology
  • Infectious Diseases

Background:

  • Clostridium difficile produces toxins A and B, leading to antibiotic-associated diarrhea and colitis.
  • C. difficile infections present a wide clinical spectrum, from asymptomatic carriage to severe, life-threatening disease.

Purpose of the Study:

  • To review the hypothesis that immune responses to C. difficile toxins mediate variations in disease presentation and course.
  • To explore the potential of immunization strategies against C. difficile toxins.

Main Methods:

  • Review of animal studies on protection via immunization against toxins A and B.
  • Analysis of human antibody responses to C. difficile toxins in the general population.
  • Examination of clinical studies correlating antitoxin responses with disease severity and recurrence.

Main Results:

  • Animal models demonstrate protection from C. difficile colitis through immunization.
  • Approximately 60% of the general population exhibits antibody responses to C. difficile toxins.
  • Clinical data suggest protective roles for serum and intestinal antitoxin responses, while inadequate responses correlate with severe or recurrent disease.

Conclusions:

  • Immune responses to C. difficile toxins A and B are critical in determining disease outcomes.
  • Developing passive and active immunization methods holds significant promise for combating C. difficile infections.
  • Targeting antitoxin immunity offers a potential therapeutic strategy for this common nosocomial pathogen.

Related Experiment Videos